Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
CONCLUSION: Using the drug sensitivity test to assess chemotherapeutics in the treatment of cervical cancer patients offers many benefits, being a first step to a clinically individualized chemotherapy.
PMID: 29552770 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | Docetaxel | Study | Taxotere